Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jil Alexandra Haase
Observed names:
Jil A Haase,
Jil A. Haase
Institutions:
National Institute of Allergy and Infectious Diseases,
Ruhr University Bochum
Observed institutions:
National Institutes of Health,
National Institute of Allergy and Infectious Diseases,
Rocky Mountain Laboratories,
Ruhr University Bochum
ORCID:
0000-0002-1206-4090
Observed ORCID:
0000-0002-1206-4090
OpenAlex ID:
A5047186944
Targeting cellular cathepsins inhibits hepatitis E virus entry
2024
·
Mara Klöhn
, Thomas Burkard
, et al.
·
Hepatology
·
34
Transmission patterns of hepatitis E virus
2025
·
Jil A Haase
, Sarah Schlienkamp
, et al.
·
Current Opinion in Virology
·
32
Fast-acting single-dose vesicular stomatitis virus-Sudan virus vaccine: a challenge study in macaques
2025
·
Paige Fletcher
, Kyle L O’Donnell
, et al.
·
The Lancet Microbe
·
15
The tyrosine kinase Yes1 is a druggable host factor of HEV
2024
·
Jil Alexandra Haase
, Abarna Baheerathan
, et al.
·
Hepatology Communications
·
12
A Single-Dose Bundibugyo Virus Vaccine Protects Macaques Within 3 Days
2026
·
Kyle L. O’Donnell
, Jil A. Haase
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
PDF
Phosphoinositide kinase PIKfyve inhibitor apilimod blocks hepatitis E virus infection
2026
·
Julian J Ring
, Sarah Schlienkamp
, et al.
·
eGastroenterology
·
3
Molecular virulence determinants of human-pathogenic filoviruses
2025
·
Jil A. Haase
, Andrea Marzi
·
Advances in virus research
·
1
Show more works
View as search
Works count:
7
Citation count:
100
H-index:
4
I10-index:
4
Year
Topic
Type